During the last decade, the advances regarding HIV treatment have marked a difference in terms of quality of life for those with HIV. By the end of 2012, according to World Health Organization, about 10 million people with HIV received treatment in countries with medium and low incomes all over the world.
Nowadays, having HIV is not considered as a “mortal disease”, which affected thousands of people during the ‘80s. It is now considered a chronic treatable infection, which means that having HIV, could be compared to have diabetes, asthma or any other health situation that requires life-long treatment in order to control the infection, and keep a normal of life.
For the first time, it was recently approved the famous “day before pill”. It’s a drug named Truvada, which is based on a combination of antiretroviral drugs that have been used in the treatment of HIV and AIDS. Truvada has begun to be used recently as a preventive treatment against the virus. As a result, according to the New York Department of Health, it would reduce the possibilities of transmission risk in more than 90%.
There is some controversy regarding the use of Truvada as a preventive treatment. The controversy, as is in the case related to the morning after pill, is the possible trivialisation of the use of a drug that is supposed to be reserved for very specific cases or accidents.
It is important to highlight and emphasize that the use of Truvada as a preventive treatment does not rule out the use of condoms. Condoms should continue to be the main tool for the prevention of HIV, and other sexually transmitted infections (STI). In addition, it is the most simple and economic way to protect ourselves. In contrast to the treatment with Truvada, it does not imply either a regime of consumption or side effects.
In summary, HIV treatment has advanced over the past years, allowing those with HIV to live to the fullest. Furthermore, condoms are the best tool to prevent the transmission of HIV. Until scientists finally find a definitive cure, we must continue to develop safe and proven strategies that allow us to give an effective response to the HIV epidemic.